Co-treatment with a C1B5 peptide of protein kinase Cγ and a low dose of gemcitabine strongly attenuated pancreatic cancer growth in mice through T cell activation.
about
Co-treatment with a C1B5 peptide of protein kinase Cγ and a low dose of gemcitabine strongly attenuated pancreatic cancer growth in mice through T cell activation.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Co-treatment with a C1B5 pepti ...... ice through T cell activation.
@en
Co-treatment with a C1B5 pepti ...... ice through T cell activation.
@nl
type
label
Co-treatment with a C1B5 pepti ...... ice through T cell activation.
@en
Co-treatment with a C1B5 pepti ...... ice through T cell activation.
@nl
prefLabel
Co-treatment with a C1B5 pepti ...... ice through T cell activation.
@en
Co-treatment with a C1B5 pepti ...... ice through T cell activation.
@nl
P2093
P2860
P1476
Co-treatment with a C1B5 pepti ...... mice through T cell activation
@en
P2093
Alejandro Zulbaran-Rojas
Andreas G Tzakos
Atsushi Kawabata
Deepthi Uppalapati
Kelsey Monson
Makoto Inui
Masaaki Tamura
Naomi Ohta
P2860
P304
P356
10.1016/J.BBRC.2017.11.102
P407
P577
2017-11-16T00:00:00Z